GlycoNex (醣聯) announced on the 6th that it has commissioned the computational simulation team at PrecisemAb Biotech (碩準生技) to utilize high-performance AI and quantum mechanics (QM) modeling for antibody design. This initiative aims to optimize antibody-glycan interaction specificity and develop novel antibodies with superior tumor selectivity.
Read more
